Latest News and Blogs

Congenica has selected the GenomOncology Precision Oncology Platform for the development of a novel ground-breaking CE-IVD Precision Oncology Solution.

Congenica announces the appointment of Robert Denison as Chief Executive Officer (CEO). He will also join the Board of the company.

Congenica wins Technology Company of the Year at the 2022 Cambridge Independent Science and Technology Awards

Congenica appoints Dr. Tom Barber as Chief Scientific Officer to lead the development and delivery of Congenica’s scientific and clinical vision

康剑尼科(Congenica)是一家数字健康公司，助力快速准确解读复杂基因组数据，为患者提供改变一生的答案。公司于今天宣布其将为香港首个大型基因组测序计划「香港基因组计划」提供全基因组测序三级数据分析。

Congenica selected to provide tertiary analysis for whole genome sequencing services for the Hong Kong Genome Project (HKGP).

Congenica forms a strategic partnership with Institute of Applied Biotechnologies (IAB) as a distributor for Czech Republic, Slovakia, Hungary and Poland.

Congenica launches service at Arab Health that creates combined digital genomic profiles from parents for comprehensive carrier screening. 

Congenica has launched a new “sample to report” service, providing additional access to sequence providers when labs have limited sequencing capacity.  

Congenica named in Impact of the 100k Genomes Pilot on rare disease diagnosis in healthcare publication in the New England Journal of Medicine

Congenica is announced as a joint winner of MIT Solve Horizon Prize

Congenica has been selected as a finalist for the prestigious Horizon Prize, powered by MIT Solve.